Catalyst Pharmaceuticals To Participate in Piper Sandler 35th Annual Healthcare Conference

<p>CORAL GABLES, Fla., Nov. 16, 2023 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases, today announced that Patrick J. McEnany, Chairman and CEO of Catalyst, along with other members of the management team, will participate at the upcoming Piper […]</p>
<p>The post <a href="https://forextv.com/top-news/catalyst-pharmaceuticals-to-participate-in-piper-sandler-35th-annual-healthcare-conference/">Catalyst Pharmaceuticals To Participate in Piper Sandler 35th Annual Healthcare Conference</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>